Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy

Published:2023-01 Issue:1 Volume:81 Page:34-45
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Maron Martin S.,Masri Ahmad,Choudhury Lubna,Olivotto Iacopo,Saberi Sara,Wang Andrew,Garcia-Pavia Pablo^ORCID,Lakdawala Neal K.,Nagueh Sherif F.,Rader Florian,Tower-Rader Albree,Turer Aslan T.,Coats Caroline,Fifer Michael A.,Owens Anjali,Solomon Scott D.,Watkins Hugh,Barriales-Villa Roberto,Kramer Christopher M.,Wong Timothy C.^ORCID,Paige Sharon L.,Heitner Stephen B.,Kupfer Stuart,Malik Fady I.,Meng Lisa,Wohltman Amy,Abraham Theodore

Publisher

Elsevier BV

Reference19 articles.

1. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy;Maron;N Engl J Med,2003

2. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Ommen;J Am Coll Cardiol,2020

3. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

4. Clinical course and management of hypertrophic cardiomyopathy;Maron;N Engl J Med,2018

5. Drug therapy for hypertrophic cardiomyopathy: physiology and practice;Sherrid;Curr Cardiol Rev,2016

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy;JACC: Heart Failure;2025-08

2. Myosin inhibitors for treatment of hypertrophic cardiomyopathy;Cochrane Database of Systematic Reviews;2025-06-23

3. Aficamten in the treatment of obstructive hypertrophic cardiomyopathy;Future Cardiology;2025-06-18

4. Cardiac myosin inhibitors: Efficacy, safety and future directions of aficamten in hypertrophic obstructive cardiomyopathy;The Egyptian Heart Journal;2025-06-13

5. Hypertrophic Cardiomyopathy and Phenocopies: New Therapies for Old Diseases—Current Evidence and Future Perspectives;Journal of Clinical Medicine;2025-06-13